Newborn Genetic Screening-Still a Role for Sanger Sequencing in the Era of NGS.
Sanger sequencing
dried bloodspots
extraction
newborn screening
Journal
International journal of neonatal screening
ISSN: 2409-515X
Titre abrégé: Int J Neonatal Screen
Pays: Switzerland
ID NLM: 101665400
Informations de publication
Date de publication:
07 Dec 2023
07 Dec 2023
Historique:
received:
16
09
2023
revised:
23
11
2023
accepted:
04
12
2023
medline:
22
12
2023
pubmed:
22
12
2023
entrez:
22
12
2023
Statut:
epublish
Résumé
In the Norwegian newborn screening (NBS) program, genetic testing has been implemented as a second or third tier method for the majority of NBS disorders, significantly increasing positive predictive value (PPV). DNA is extracted from dried blood spot (DBS) filter cards. For monogenic disorders caused by variants in one single gene or a few genes only, Sanger sequencing has been shown to be the most time- and cost-efficient method to use. Here, we present the Sanger sequencing method, including primer sequences and the genetic test algorithms, currently used in the Norwegian newborn screening program.
Identifiants
pubmed: 38132826
pii: ijns9040067
doi: 10.3390/ijns9040067
pii:
doi:
Types de publication
Journal Article
Langues
eng